MAPT and Alzheimer disease: Rather, previous post-mortem and tau-PET imaging studies reported that an earlier AD symptom onset is associated with a different spatial distribution pattern of tau pathology10,12, i.e., the key driver of neurodegeneration13 and cognitive decline in AD14,15.